Total submissions: 2
| Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
|---|---|---|---|---|---|---|---|---|
| Invitae | RCV000896629 | SCV001040733 | likely benign | not provided | 2018-02-20 | criteria provided, single submitter | clinical testing | |
| Department of Pathology and Laboratory Medicine, |
RCV000896629 | SCV001553120 | uncertain significance | not provided | no assertion criteria provided | clinical testing | The PLCD1 p.Asn28Asp variant was not identified in the literature nor was it identified in ClinVar, Cosmic or LOVD 3.0. The variant was identified in dbSNP (ID: rs143961610) and was also found in control databases in 92 of 276286 chromosomes at a frequency of 0.000333 (Genome Aggregation Database Feb 27, 2017). The variant was observed in the following population: African in 86 of 23942 chromosomes (freq: 0.003592) and Latino in 6 of 35310 chromosomes (freq: 0.00017), while the variant was not observed in the Ashkenazi Jewish, East Asian, European (Finnish), European (non-Finnish), Other or South Asian populations. The variant occurs outside of the splicing consensus sequence and in silico or computational prediction software programs (SpliceSiteFinder, MaxEntScan, NNSPLICE, GeneSplicer) do not predict a difference in splicing. The p.Asn28 residue is not conserved in mammals and four out of five computational analyses (SIFT, AlignGVGD, BLOSUM, MutationTaster) do not suggest a high likelihood of impact to the protein; however, this information is not predictive enough to rule out pathogenicity. In summary, based on the above information the clinical significance of this variant cannot be determined with certainty at this time. This variant is classified as a variant of uncertain significance. |